Follow us on Facebook

One on One Support

Health Concerns
VA Issues  

 


Information:
Notice: Website under construction,
Contact
HCVets@gmail.com  
 

May 2014 VA Hep C Treatment Guidelines
UPDATE: Feb 26, 2016-
Funding and Prioritization Status Update

UPDATE: March 2016
VA Hep C Treatment Guidelines
VA to treat all vets in system
 

By Judith Graham
VA Extends New Hepatitis C Drugs to All Veterans in Its Health System

 
Orange Count Registry
Vietnam vets blame 'jet guns' for their hepatitis C
By Lily Leung Feb. 14, 2016 
 
CBS News Investigates
Congress outraged over hepatitis C treatment VA can't afford
Dr. Raymond Schinazi played a leading role developing a drug that cures hepatitis C while working seven-eighths of his time for the VA
 
ibtimes.com| By amynordrum
 


Hepatitis C drug costing VA, DoD millions
By Patricia Kime, Staff writer
We're looking at a company who is milking a cash cow for everything it's worth," Sanders said. 
 


VA to outsource care for 180,000 vets with hepatitis C
Dennis Wagner, The Arizona Republic 12:27 a.m. EDT June 21, 2015
 


VA to outsource care for 180,000 vets with hepatitis C
, The Republic | azcentral.com 11:51 a.m. MST June 19, 2015
Dr. David Ross, the VA's director public-health pathogens programs, resigned from the working group. "I cannot in good conscience continue to work on a plan for rationing care to veterans," he wrote.
 


VA Region Stops Referring Patients To Outside Hospitals Thanks To Budget Shortfall
Michael Volpe Contributor ...According to a memo — the entire region has been forced to stop all “non-VA care” referrals due to a budget shortfall.
 

DisabledVeterans.org
OIG INVESTIGATES VA CHOICE PROGRAM PROBLEMS
Sen. Mark Kirk admitted the VA Choice Program is a failed joke in a letter to Secretary Bob McDonald despite attempts to fix it.
 

 
Denied Hep C VA dental care?
Please click here

 
Dried Hepatitis C Blood Exposure 11/23/2013 Weeks later inconspicuous blood transmits virus and more likely to cause accidental exposures to Hep C
 

Lack of Standards for
Mass Vaccinations
1970 Jetgun Nursing Instructions
 

2014 AASLD Study Hepatitis C not an STD

Home
Test the Rest Campaign
Documentation & Surveillance Alerts
Military Hepatitis History  
Understanding The Liver 
VA Flow Sheet for Cirrhosis
VA Defines Risk Factors
 
Hep C & Pro-Prebiotic
Need to know-Grassroots Research
 
Blog Another12Weeks
One Vets' Journey Though Treatment
 

 Ask NOD
 What Would Veterans Do?
Blog for VA Claims
 


Help with VA Claims
 


 
Info: Plan Backfires-
VBA Fast Letter Boost Claims
 
Legal- Fed Regs state:
Judge decision may be relied upon
Cotant v. Principi, 17 Vet.App. 116, 134 (2003),
 
Service Connected Claims
# 1 Conclusion of Law 
# 2 Conclusion of Law 
 
More Claims
Jetgun Decisions
Hep C Decisions
 
Search Board of Appeals Website
BVA Jetgun Decisions
BVA Hepatitis C Decisions

Great Advice!  
After the jetgun win
What to do next

 


At the end of February 1994, Baxter Healthcare announced the removal of Gammagard from the global market because of plasma used was positive for hepatitis C. In July 1995, the FDA said that as many as 1,000 cases of hepatitis C could have been linked to use of Gammagard.

In September 2000, the U.S.D.C. for the Central District of California approved a settlement of the class action (MDL NO. 95-1060-R) providing financial compensation for U.S. individuals who used Gammagard between January 1993 and February 1994. In September 2000, the U.S.D.C. for the Central District of California approved a settlement of the class action (MDL NO. 95-1060-R) providing financial compensation for U.S. individuals who used Gammagard between January 1993 and February 1994. Plaintiffs accused Baxter for negligence, strict liability, breach of implied and express warranty, fraud, misrepresentation, and infliction of emotional distress. According to the settlement, the number of patients receiving Gammagard during this period is not known but is estimated to be several thousand.

UPDATE:

Baxter submits Application for FDA Approval of Gammagard Liquid -
AttorneyOne.com informs: you can still file a claim and receive compensation for Gammagard side effects

PRWeb

Published 10:00 a.m., Monday, March 12, 2012

Read more: http://www.timesunion.com/business/press-releases/article/Baxter-submits-Application-for-FDA-Approval-of-3398986.php#ixzz1p0E7VElj

On January 9th, 2012 Baxter announced it submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of Gammagard Liquid 10% (Immune Globulin Infusion) for the treatment of multifocal motor neuropathy (MMN). Gammagard is an intravenous solution that is made from human plasma. It is a sterile solution, which helps the body maintain immunity and fight disease. At the end of February 1994, Baxter (the company manufacturing Gammagard) announced it was removing it from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Gammagard side effects [http://www.attorneyone.com/gammagard-lawsuits/ .

San Diego, CA (PRWEB) March 12, 2012

The media spotlight is often a double-edged sword. No one knows this better than people who tried Gammagard and experience severe side effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.



As announced on Jan. 9th, 2012, Baxter International Inc. submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of GAMMAGARD LIQUID 10% (Immune Globulin Infusion) for the treatment of multifocal motor neuropathy (MMN). The product, marketed as KIOVIG outside the United States and Canada, was approved for the MMN indication in Europe in 2011.



The filing is based on a Phase III, randomized, double-blind, placebo-controlled, cross-over, multi-center study of the efficacy, safety, and tolerability of Gammagard Liquid 10% in a total of 44 MMN patients.



At the end of February 1994, Baxter Healthcare announced the removal of Gammagard from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. In July 1995, the FDA said that as many as 1,000 cases of hepatitis C could have been linked to use of Gammagard.



In September 2000, the U.S.D.C. for the Central District of California approved a settlement of the class action (MDL NO. 95-1060-R) providing financial compensation for U.S. individuals who used Gammagard between January 1993 and February 1994. Plaintiffs accused Baxter for negligence, strict liability, breach of implied and express warranty, fraud, misrepresentation, and infliction of emotional distress. According to the settlement, the number of patients receiving Gammagard during this period is not known but is estimated to be several thousand.



AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Gammagard Side Effects, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe side effects from Gammagard remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”



On January 15th, 2010, the US Food and Drug Administration issued a warning to Baxter citing significant deviations from good manufacturing practices (cGMP) in the manufacture of Gammagard liquid and Gammagard S/D intermediates at its manufacturing facility in Belgium.



If you have recently been diagnosed with Hepatitis C and you took Gammagard, you might be able to file a Gammagard Side Effects lawsuit.



AttorneyOne.com has further information on Gammagard lawsuits including how to get in contact with legal counsel.



Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. Checkout earlier legal news from us at
http://www.prweb.com/releases/2012/3/prweb9256792.htm .


For the original version on PRWeb visit:
http://www.prweb.com/releases/prweb2012/3/prweb9266831.htm


Read more:
http://www.timesunion.com/business/press-releases/article/Baxter-submits-Application-for-FDA-Approval-of-3398986.php#ixzz1p0JFYF00